Aegon Ltd. AEG
NYSE
$8.33+0.03 (+0.36%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Aegon (ENXTAM:AGN) stays in focus after investors reviewed fresh return data alongside its broad insurance footprint across the Americas, the Netherlands, the United Kingdom and other markets, putting recent share performance under closer scrutiny. Aegon’s share price has slipped over the past month and quarter, even as the year-to-date share price return sits in double digits and the 1-year and 5-year total shareholder returns of 17.6% and 121.3% point to momentum that has built over a...
Aegon has delivered a powerful 5 year run, yet the recent pullback leaves a clear question on the table for investors who care about what they are paying for each euro of earnings. With the stock now around €7.39 and corporate changes underway, the focus turns to whether those earnings are strong enough to support today’s valuation. Over the past 5 years the share price has gained 119.0%, which puts real pressure on the question of whether profit generation has kept pace with the market’s...
Schiphol, October 8, 2026 - Aegon Ltd.’s Extraordinary General Meeting of Shareholders (EGM) today approved both the Redomiciliation and the Omnibus Incentive Plan proposal, giving Aegon the mandate to proceed with its redomiciliation to the US. Consequently, Aegon expects to proceed on October 15, 2026, with the repurchase of all outstanding Common Shares B held by Vereniging Aegon in exchange for common shares with equal voting rights on a 40-to-1 basis, upon completion of which the interim by
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.